Von Willebrand Disease: Assessment and Diagnostic Testing
Author and Disclosure Information [Show]

Natalia Rydz, MD, FRCPC
Clinical Assistant Professor, Division of Hematology and Hematologic Malignancies, Foothills Medical Centre, Calgary AB, Canada

Question 1 of 5

A 30-year-old man presents with prolonged bleeding after a dental extraction. Mild hemophilia A is suspected based on a baseline factor VIII (FVIII) level of 9 IU/dL. Further testing reveals the following: genotyping is negative for an F8 mutation; a desmopressin (DDAVP) trial shows a brisk but short-lived FVIII response; von Willebrand factor antigen (VWF:Ag) level is 0.55 IU/dL; and VWF ristocetin cofactor (VWF:RCo) is 0.50 IU/dL.

What is the next most useful test?

Low-dose ristocetin-induced platelet aggregation

Mixing studies

VWF:collagen binding assay

VWF:FVIII binding assay

VWF multimer analysis

Hospital Physician: Hematology/Oncology. 2018 March;13(2)

This quiz is not accredited for CME.

More from Board Review Questions: Hematology/Oncology


Small Cell Lung Cancer
Management of Metastatic Gastric Cancer
Transfusion Medicine
Acute Myeloid Leukemia
Management of Colorectal Cancer in Older Adults
Urothelial Carcinoma: Muscle-Invasive and Metastatic Disease
Pancreatic Adenocarcinoma: Advanced Unresectable and Metastatic Disease
HER2-Positive Breast Cancer
Aggressive B-Cell Non-Hodgkin Lymphoma
Von Willebrand Disease: Clinical Management
Pancreatic Adenocarcinoma: Neoadjuvant and Adjuvant Treatment
Late Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Polycythemia Vera and Essential Thrombocythemia: Current Management
Treatment of Biliary Tract Cancers
Early Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Hairy Cell Leukemia
Genomic Testing in Women with Early-Stage Hormone Receptor–Positive, HER2-Negative Breast Cancer
Immune Thrombocytopenia
Cancer-Related Fatigue
Disseminated Intravascular Coagulation
Advanced Stage and Relapsed/Refractory Hodgkin Lymphoma
Adjuvant Chemotherapy for Colon Cancer
Molecular Markers and Targeted Therapies in the Management of Non-Small Cell Lung Cancer
Metastatic Cutaneous Melanoma: Targeted Therapy and Immunotherapy
Thrombosis in Pregnancy
Locally Advanced Pancreatic Cancer
Early-Stage Hodgkin Lymphoma
Neoadjuvant and Adjuvant Therapy for Gastric Cancer
Hemophilia A and B
Mantle Cell Lymphoma
Soft Tissue Sarcoma
Sickle Cell Disease
Renal Cell Carcinoma
Management of Locally Advanced Rectal Adenocarcinoma
Adjuvant Systemic Therapy for Early-Stage Breast Cancer
Chronic Myeloid Leukemia
Plasma Cell Disorders
Myelodysplastic Syndromes
Acute and Chronic Graft-versus-Host Disease